Sökresultat - Slamon, Dennis

Frozen Tumor Tissue Microarray Technology for Analysis of Tumor RNA, DNA, and Proteins av Schoenberg Fejzo, Marlena, Slamon, Dennis J.

Hämta fulltext Hämta fulltext

Potential Utility of an Expression Array Signature for Predicting Anthracycline Responsiveness or Resistance av Press, Michael F., Gordon, Michael A., Slamon, Dennis J.

Hämta fulltext Hämta fulltext Hämta fulltext

FOXO1A is a target for HER2 Overexpressing Breast Tumors av Wu, Yanyuan, Shang, Xiying, Sarkissyan, Marianna, Slamon, Dennis, Vadgama, Jaydutt V.

Hämta fulltext Hämta fulltext Hämta fulltext

The two single nucleotide polymorphisms in the H37/RBM5 tumour suppressor gene at 3p21.3 correlated with different subtypes of non-small cell lung cancers av Oh, Juliana J., Koegel, Ashley, Phan, Diana T., Razfar, Ali, Slamon, Dennis J.

Hämta fulltext Hämta fulltext Hämta fulltext

A model-based approach for assessing in vivo combination therapy interactions av Lopez, Angela M., Pegram, Mark D., Slamon, Dennis J., Landaw, Elliot M.

Hämta fulltext Hämta fulltext

Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation av Wu, Yanyuan, Alvarez, Monica, Slamon, Dennis J, Koeffler, Phillip, Vadgama, Jaydutt V

Hämta fulltext Hämta fulltext Hämta fulltext

Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer av Wu, Yanyuan, Mohamed, Hezla, Chillar, Ram, Ali, Ishrat, Clayton, Sheila, Slamon, Dennis, Vadgama, Jaydutt V

Hämta fulltext Hämta fulltext Hämta fulltext

Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab resistant HER2-overexpressing breast cancer cells av Wu, Yanyuan, Ginther, Charles, Kim, Juri, Mosher, Nicole, Chung, Seyung, Slamon, Dennis, Vadgama, Jaydutt V.

Hämta fulltext Hämta fulltext Hämta fulltext

RIN1 is a Breast Tumor Suppressor Gene av Milstein, Marc, Mooser, Chelsea K., Hu, Hailiang, Fejzo, Marlena, Slamon, Dennis, Goodglick, Lee, Dry, Sarah, Colicelli, John

Hämta fulltext Hämta fulltext Hämta fulltext

CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors av Xu, Jinhua, Huo, Dezheng, Chen, Yinghua, Nwachukwu, Chika, Collins, Cindy, Rowell, Janelle, Slamon, Dennis J., Olopade, Olufunmilayo I.

Hämta fulltext Hämta fulltext Hämta fulltext

Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies av Esteva, Francisco J, Cheli, Carol D, Fritsche, Herbert, Fornier, Monica, Slamon, Dennis, Thiel, Robert P, Luftner, Diana, Ghani, Farooq

Hämta fulltext Hämta fulltext Hämta fulltext

Inhibitors of Protein Geranylgeranyltransferase I and Rab Geranylgeranyltransferase Identified from a Library of Allenoate-derived Compounds av Watanabe, Masaru, Fiji, Hannah D. G., Guo, Lea, Chan, Lai, Kinderman, Sape S., Slamon, Dennis J., Kwon, Ohyun, Tamanoi, Fuyuhiko

Hämta fulltext Hämta fulltext Hämta fulltext

Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient av Lu, Nu T., Raizer, Jeffrey, Gabor, Erwin P., Liu, Natalie M., Vu, James Q., Slamon, Dennis J., Barstis, John L.

Hämta fulltext Hämta fulltext Hämta fulltext

Clinical evaluation of BCL-2/X(L) levels pre- and post- HER2-targeted therapy av Zoeller, Jason J., Press, Michael F., Selfors, Laura M., Dering, Judy, Slamon, Dennis J., Hurvitz, Sara A., Brugge, Joan S.

Hämta fulltext Hämta fulltext Hämta fulltext

Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: A pilot study av Britten, Carolyn D, Gomes, Antoinette S, Wainberg, Zev A, Elashoff, David, Amado, Rafael, Xin, Yan, Busuttil, Ronald W, Slamon, Dennis J, Finn, Richard S

Hämta fulltext Hämta fulltext Hämta fulltext

Systemic Therapy for Metastatic Renal Cell Carcinoma: A Review and Update av Logan, Joshua E, Rampersaud, Edward N, Sonn, Geoffrey A, Chamie, Karim, Belldegrun, Arie S, Pantuck, Allan J, Slamon, Dennis J, Kabbinavar, Fairooz F

Hämta fulltext Hämta fulltext

A Phase I/II Trial of Trastuzumab plus Erlotinib in Metastatic HER2-Positive Breast Cancer: A Dual ErbB Targeted Approach av Britten, Carolyn D., Finn, Richard S., Bosserman, Linda D., Wong, Steven G., Press, Michael F., Malik, Mubashira, Lum, Bert L., Slamon, Dennis J.

Hämta fulltext Hämta fulltext Hämta fulltext

Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer av Fejzo, Marlena S., Anderson, Lee, von Euw, Erika M., Kalous, Ondrej, Avliyakulov, Nuraly K., Haykinson, Michael J., Konecny, Gottfried E., Finn, Richard S., Slamon, Dennis J.

Hämta fulltext Hämta fulltext Hämta fulltext

Pleiotrophin mediates hematopoietic regeneration via activation of RAS av Himburg, Heather A., Yan, Xiao, Doan, Phuong L., Quarmyne, Mamle, Micewicz, Eva, McBride, William, Chao, Nelson J., Slamon, Dennis J., Chute, John P.

Hämta fulltext Hämta fulltext Hämta fulltext

Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-posit... av Hurvitz, Sara A, Bosserman, Linda D, Chan, David, Hagenstad, Christopher T, Kass, Frederick C, Smith, Frederick P, Rodriguez, Gladys I, Childs, Barrett H, Slamon, Dennis J

Hämta fulltext Hämta fulltext Hämta fulltext